The United States ceased airport screenings for COVID-19 on September 14, 2020, following insights that revealed the ineffectiveness of such measures in controlling the virus’s spread. This marked a significant shift in the approach to public health safety, particularly concerning international travel.
Initially introduced in January 2020 by the Centres for Disease Control and Prevention (CDC), the airport screening initiative was aimed at curbing the transmission of the coronavirus, which had originated in China and rapidly infiltrated numerous countries. The CDC’s intent was clear: to diminish the number of COVID-19 cases entering the U.S. and to mitigate further outbreaks within the country.
The screening process involved assessing travellers who had recently returned from specific hotspot regions identified by health officials. These individuals underwent temperature checks with infrared thermometers and were observed for any visible signs of illness. Additionally, they were required to answer a questionnaire detailing any symptoms they might be experiencing.
Initially, the screening included mandatory quarantines for travellers arriving from Hubei Province, China, which were later extended to encompass all travellers from mainland China and eventually added nations such as Iran and several European countries, including the United Kingdom. These measures required affected travellers to isolate for 14 days upon arrival in the U.S. and were designed to prevent the unchecked spread of the virus.
At its peak on March 20, 2020, the program mobilised around 750 screening officials across 15 major airports. In total, over 766,000 travellers were screened from January until the programme’s closure in September. New York’s John F. Kennedy Airport handled the highest volume of screenings, accounting for around 20% of the total number of passengers evaluated.
Despite the extensive screening efforts, the outcomes were underwhelming. Only 298 travellers – approximately 0.04% – were deemed fit for referral to medical treatment. This data translated to one referral for every 85,000 individuals screened, prompting CDC officials to reconsider the overall effectiveness of the programme.
One of the key challenges that emerged was the nature of COVID-19 itself. Many infected individuals were asymptomatic, allowing the virus to spread undetected. Moreover, travellers could potentially conceal symptoms or use measures like cough suppressants to avoid detection, thereby rendering the screening process less effective. This was highlighted in the CDC report, which indicated that coughing was the primary reason for referrals, accounting for 202 of the 298 cases.
As a result of the limited success and significant resource demands of the programme, the CDC concluded that airport screenings were not a viable solution for controlling the epidemic. The complexities of asymptomatic transmission coupled with the varied clinical presentations of COVID-19 ultimately led to the announcement that screenings would come to an end.
The decision to halt these procedures reflects broader lessons learned regarding pandemic response strategies and the inherent limitations of screening mechanisms. As the world continues to navigate the ongoing impacts of the COVID-19 pandemic, these findings contribute to an evolving understanding of effective public health practices in managing infectious diseases within travel and transportation settings.